I can understand the importance of having an outcome assessor independent and blinded of intervention for a Randomised Controlled Trial (RCT), but when conducting a Case Study investigating a new Clinical Health intervention is it also important to NOT allow the principal researcher to carry out baseline and post-intervention outcome scales/measures?

My understanding is that the principal objective of a Case Study is to establish the feasibility of a new intervention rather than effectiveness and more importantly ensure that the participant does not experience any adverse effects. Because of this, the significance of any non-feasibility scales are minimal so for this reason would it be a poor design for the principal researcher to undertake the outcome scales/measures?

Thank you for your advice regarding this question!

Ken

More Kenneth Monaghan's questions See All
Similar questions and discussions